Page last updated: 2024-10-22

alendronate and Attachment Loss, Periodontal

alendronate has been researched along with Attachment Loss, Periodontal in 3 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Research Excerpts

ExcerptRelevanceReference
"Alendronate sodium is a potent inhibitor of bone resorption which has been effectively used to control osteolysis, and to treat Paget's disease and osteoporosis."6.71The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial). ( El-Shinnawi, UM; El-Tantawy, SI, 2003)
"Considering the emerging role of host-inflammatory response in treatment of periodontitis and the antiresorptive and osteostimulative properties of bisphosphonates, several studies are focusing on the role of alendronate as an addition to non-surgical periodontal therapy."5.22Added effect of 1% topical alendronate in intra-bony and inter-radicular defects as part of step II periodontal therapy: a systematic review with meta-analysis and trial sequential analysis. ( Arena, C; Caponio, VCA; Lo Muzio, L; Lo Russo, L; Troiano, G; Zhurakivska, K, 2022)
"Alendronate sodium is a potent inhibitor of bone resorption which has been effectively used to control osteolysis, and to treat Paget's disease and osteoporosis."2.71The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial). ( El-Shinnawi, UM; El-Tantawy, SI, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Arena, C1
Caponio, VCA1
Zhurakivska, K1
Lo Russo, L1
Lo Muzio, L1
Troiano, G1
Carvalho Dutra, B1
Oliveira, AMSD1
Oliveira, PAD1
Miranda Cota, LO1
Silveira, JO1
Costa, FO1
El-Shinnawi, UM1
El-Tantawy, SI1

Reviews

1 review available for alendronate and Attachment Loss, Periodontal

ArticleYear
Added effect of 1% topical alendronate in intra-bony and inter-radicular defects as part of step II periodontal therapy: a systematic review with meta-analysis and trial sequential analysis.
    BMC oral health, 2022, 01-21, Volume: 22, Issue:1

    Topics: Alendronate; Alveolar Bone Loss; Diphosphonates; Humans; Periodontal Attachment Loss; Periodontitis

2022

Trials

2 trials available for alendronate and Attachment Loss, Periodontal

ArticleYear
Effects of topical application of 1% sodium alendronate gel in the surgical treatment of periodontal intrabony defects: A 6-month randomized controlled clinical trial.
    Journal of periodontology, 2019, Volume: 90, Issue:10

    Topics: Alendronate; Alveolar Bone Loss; Follow-Up Studies; Guided Tissue Regeneration, Periodontal; Humans;

2019
The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial).
    Journal of the International Academy of Periodontology, 2003, Volume: 5, Issue:1

    Topics: Absorptiometry, Photon; Adult; Alendronate; Alveolar Bone Loss; Alveolar Process; Bone Density; Dent

2003